2001

Nov 9, 2001
Guidant and Cook Announce FDA Approval To Begin U.S. Clinical Trial With Paclitaxel-Coated Stent

First U.S. Patient Treated in Pivotal Clinical Trial Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and Cook Incorporated today announced Investigational Device Exemption (IDE)...

Nov 8, 2001
Guidant to Host Vascular Intervention Investor Briefing at AHA

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...

Nov 7, 2001
Guidant and Merck KGaA Collaborate on Heart Failure Education

International Symposium Offers Unique Opportunity for Experts in Device Technology and Drug Therapy to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored...

Nov 6, 2001
Guidant Announces First Human Implant of Newest Active-Fixation Defibrillation Lead

Defibrillation Lead Features Advances in Handling and Visibility for Ease in Positioning Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Nov 5, 2001
Guidant's Automated Radiotherapy Treatment for Coronary Artery Disease Receives FDA Approval

GALILEO System Sets New Standards of Precision and Ease of Use Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary...

Show per page

Top